Top compounds associated with response to CRYAA


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA PX-12 CTRPv2 pan-cancer AAC 0.011 0.7
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.03 0.7
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA PF-184 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA JW-55 CTRPv2 pan-cancer AAC -0.031 0.7
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.029 0.7
Download CSV